Plus: Paul Hitchin succeeds Laetitia Rouxel as CFO of Evotec, and updates from Elekta, Forx, Abzena and more

Plus: Woodcock, Kim join Friends of Cancer Research’s board and updates from Recursion, Medtronic and more

Led by former banker Pierre Arsène, the start-up’s first goal is surveillance of cirrhosis patients at risk of liver cancer

Week’s management moves include new venture partners at Frazier and updates from Beigene, Intellia and more

Plus: CMO changes at Centessa, Lifordi, Rapport and Gemma, and updates from Peptone, Labgenius, Mitorx and more

Temporary respite or reflection of a stabilizing sector?

Plus: Structure strengthens team and updates from RegenxBio, Mirador, Abata, Entact, Nautilus and more

Plus: C-suite changes at Dyne, and updates from Novocure, Amphista, reMYND, Belite Bio, Forward and more 

At least 20 companies have trimmed pipelines, cut staff or otherwise re-jiggered strategies in past two weeks to extend runway